miércoles, 18 de junio de 2025

HIV protection with just two shots a year: FDA approves Gilead drug Lenacapavir, to be sold as Yeztugo, has potential to bring AIDS pandemic to heel but faces Trump-era obstacles

https://www.statnews.com/2025/06/18/fda-approves-gilead-hiv-prevention-drug-lenacapavir-yeztugo-next-best-thing-to-vaccine/

No hay comentarios: